BiomX (PHGE) Insider Trading & Ownership $0.62 -0.12 (-16.78%) Closing price 10/9/2025 03:59 PM EasternExtended Trading$0.61 0.00 (-0.49%) As of 10/9/2025 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartHeadlinesInsider TradesOwnershipSEC FilingsBuy This Stock BiomX (NYSEMKT:PHGE) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.00%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)$84.38KNumber OfInsiders Selling(Last 3 Years)2Amount OfInsider Selling(Last 3 Years)$32.95K Get PHGE Insider Trade Alerts Want to know when executives and insiders are buying or selling BiomX stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PHGE Insider Buying and Selling by Quarter BiomX Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/15/2024Israel Biofund Gp Limi OrbimedMajor ShareholderSell2,434$3.80$9,249.20 5/22/2023Assaf OronInsiderBuy319$2.70$861.30 2/27/2023Israel Biofund Gp Limi OrbimedMajor ShareholderBuy34,800$2.40$83,520.00 11/4/2022Chidozie UgwumbaMajor ShareholderSell150$3.80$570.00 11/2/2022Chidozie UgwumbaMajor ShareholderSell241$3.60$867.60 10/31/2022Chidozie UgwumbaMajor ShareholderSell330$3.70$1,221.00 10/28/2022Chidozie UgwumbaMajor ShareholderSell152$3.60$547.20 10/26/2022Chidozie UgwumbaMajor ShareholderSell1,250$3.50$4,375.00 10/24/2022Chidozie UgwumbaMajor ShareholderSell590$3.50$2,065.00 10/21/2022Chidozie UgwumbaMajor ShareholderSell540$3.70$1,998.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 10/19/2022Chidozie UgwumbaMajor ShareholderSell450$3.70$1,665.00 10/17/2022Chidozie UgwumbaMajor ShareholderSell809$3.40$2,750.60 10/14/2022Chidozie UgwumbaMajor ShareholderSell342$3.30$1,128.60 10/12/2022Chidozie UgwumbaMajor ShareholderSell970$3.30$3,201.00 10/10/2022Chidozie UgwumbaMajor ShareholderSell1,004$3.30$3,313.20 (Data available from 1/1/2013 forward) PHGE Insider Trading Activity - Frequently Asked Questions Who is on BiomX's Insider Roster? The list of insiders at BiomX includes Assaf Oron, Chidozie Ugwumba, and Israel Biofund Gp Limi Orbimed. Learn more on insiders at PHGE. What percentage of BiomX stock is owned by insiders? 3.00% of BiomX stock is owned by insiders. Learn more on PHGE's insider holdings. Which BiomX insiders have been selling company stock? The following insider sold PHGE shares in the last 24 months: Israel Biofund Gp Limi Orbimed ($9,249.20). How much insider selling is happening at BiomX? Insiders have sold a total of 2,434 BiomX shares in the last 24 months for a total of $9,249.20 sold. BiomX Key ExecutivesMr. Jonathan Eitan Solomon MBA (Age 47)CEO & Director Compensation: $714.37kDr. Merav Bassan Ph.D. (Age 58)Chief Development Officer Compensation: $437.71kMs. Marina Wolfson CPA (Age 40)CFO & Secretary (Leave of Absence) Compensation: $337.51kProf. Rotem Sorek Ph.D.Scientific FounderDr. Eran Elinav M.D.Ph.D., Scientific FounderDr. Timothy K. Lu M.D. (Age 43)Ph.D., Scientific Founder Mr. Avraham Gabay (Age 38)Interim Chief Financial Officer Ms. Inbal Benjamini-ElranC.H.R.OMr. Assaf Oron (Age 50)Chief Business Officer Compensation: $352.04k More Insider Trading Tools from MarketBeat Related Companies Cue Biopharma Insider Trades MAIA Biotechnology Insider Trades Celularity Insider Trades Karyopharm Therapeutics Insider Trades RenovoRx Insider Trades ZIVO Bioscience Insider Trades FibroGen Insider Trades Dyadic International Insider Trades Aadi Bioscience Insider Trades Oncobiologics Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Marvell Insiders Buy Shares—Should Investors Follow Suit?This Insider Just Made a Massive Bet on Transocean's ComebackInsider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?Oklo Insiders Sell! Oh No! This Is Why Investors Shouldn’t WorryTop Insider Buys and Sells From September: Buy, Sell, or Hold? This page (NYSEMKT:PHGE) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersElon callingElon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia and AMD just surged. But this setup was already winning.Last week, Nvidia and AMD stock soared as export restrictions eased. Nvidia alone gained nearly 5% in a sin...Timothy Sykes | SponsoredHave you heard of the Texas Royalty Plan?There is a backdoor way you could collect a check, four times a year, thanks to the exploding oil industry in ...Brownstone Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BiomX Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BiomX With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.